Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1Seizures 1Epilepsy 1Cognitive Dysfunction 1

Interventions

Neuropsychological Tests 2Vitamin D 1Standard of Care 1Silymarin 1Physical Conditioning, Human 1Patient Reported Outcome Measures 1Mindfulness 1Geriatric Assessment 1Exergaming 1Counseling 1Coping Skills 1Cognitive Training 1Blood Specimen Collection 1Aspirin 1Ashwagandha 1Anticonvulsants 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cognitive Dysfunction × Anticonvulsants × Clear all
NCT03356769 2020-06-09

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Peking Union Medical College Hospital

Phase 2 Unknown
98 enrolled

Epilepsy, Seizures, Tuberous Sclerosis, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡